Arcturus Therapeutics Holdings Inc. shares advanced 5.8% following the announcement of a new deal with Thermo Fisher Scientific Inc. The partnership is expected to bolster Arcturus's operational capabilities and market position.
Arcturus Therapeutics Rises 5.8% on Thermo Fisher Partnership
BiotechnologyCorporate DealsStock PerformanceHealthcare Sector



